“Rational Vaccine Design” for HIV Should Take into Account the Adaptive Potential of Polyreactive Antibodies

1. MascolaJRMontefioriDC 2010 The role of antibodies in HIV vaccines. Annu Rev Immunol 28 413 444

2. Karlsson HedestamGBFouchierRAPhogatSBurtonDRSodroskiJ 2008 The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 6 143 155

3. PantophletRBurtonDR 2006 GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24 739 769

4. KwongPDDoyleMLCasperDJCicalaCLeavittSA 2002 HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420 678 682

5. WeiXDeckerJMWangSHuiHKappesJC 2003 Antibody neutralization and escape by HIV-1. Nature 422 307 312

6. StamatatosLMorrisLBurtonDRMascolaJR 2009 Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 15 866 870

7. WalkerLMPhogatSKChan-HuiPYWagnerDPhungP 2009 Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326 285 289

8. KwongPDWilsonIA 2009 HIV-1 and influenza antibodies: seeing antigens in new ways. Nat Immunol 10 573 578

9. JoyceJGter MeulenJ 2010 Pushing the envelope on HIV-1 neutralization. Nat Biotechnol 28 929 931

10. WuXYangZYLiYHogerkorpCMSchiefWR 2010 Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329 856 861

11. ZhouTGeorgievIWuXYangZYDaiK 2010 Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329 811 817

12. CalareseDAScanlanCNZwickMBDeechongkitSMimuraY 2003 Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300 2065 2071

13. SaphireEOParrenPWPantophletRZwickMBMorrisGM 2001 Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 293 1155 1159

14. ChoeHLiWWrightPLVasilievaNVenturiM 2003 Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell 114 161 170

15. PejchalRWalkerLMStanfieldRLPhogatSKKoffWC 2010 Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1. Proc Natl Acad Sci U S A 107 11483 11488

16. MouquetHScheidJFZollerMJKrogsgaardMOttRG 2010 Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467 591 595

17. NotkinsAL 2004 Polyreactivity of antibody molecules. Trends Immunol 25 174 179

18. EisenHNChakrabortyAK 2010 Evolving concepts of specificity in immune reactions. Proc Natl Acad Sci U S A 107 22373 22380

19. EhrensteinMRNotleyCA 2010 The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10 778 786

20. OchsenbeinAFFehrTLutzCSuterMBrombacherF 1999 Control of early viral and bacterial distribution and disease by natural antibodies. Science 286 2156 2159

21. ZhouZHZhangYHuYFWahlLMCisarJO 2007 The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1 51 61

22. KleinJSBjorkmanPJ 2010 Few and far between: how HIV may be evading antibody avidity. PLoS Pathog 6 e1000908 doi:10.1371/journal.ppat.1000908

23. AlamSMMcAdamsMBorenDRakMScearceRM 2007 The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J Immunol 178 4424 4435

24. SchererEMLeamanDPZwickMBMcMichaelAJBurtonDR 2010 Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions. Proc Natl Acad Sci U S A 107 1529 1534

25. DiskinRMarcovecchioPMBjorkmanPJ 2010 Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Nat Struct Mol Biol 17 608 613

26. ManivelVSahooNCSalunkeDMRaoKV 2000 Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site. Immunity 13 611 620

27. ManivelVBayirogluFSiddiquiZSalunkeDMRaoKV 2002 The primary antibody repertoire represents a linked network of degenerate antigen specificities. J Immunol 169 888 897

28. LederLBergerCBornhauserSWendtHAckermannF 1995 Spectroscopic, calorimetric, and kinetic demonstration of conformational adaptation in peptide-antibody recognition. Biochemistry 34 16509 16518

29. CooperA 1999 Thermodynamic analysis of biomolecular interactions. Curr Opin Chem Biol 3 557 563

30. KomissarovAADeutscherSL 1999 Thermodynamics of Fab-ssDNA interactions: contribution of heavy chain complementarity determining region 3. Biochemistry 38 14631 14637

31. SwaminathanCPNandiAVisweswariahSSSuroliaA 1999 Thermodynamic analyses reveal role of water release in epitope recognition by a monoclonal antibody against the human guanylyl cyclase C receptor. J Biol Chem 274 31272 31278

32. KangJWarrenAS 2007 Enthalpy-entropy compensation in the transition of a monospecific antibody towards antigen-binding promiscuity. Mol Immunol 44 3623 3624

33. SchreiberGKeatingAE 2011 Protein binding specificity versus promiscuity. Curr Opin Struct Biol 21 50 61

34. JimenezRSalazarGYinJJooTRomesbergFE 2004 Protein dynamics and the immunological evolution of molecular recognition. Proc Natl Acad Sci U S A 101 3803 3808

35. JamesLCRoversiPTawfikDS 2003 Antibody multispecificity mediated by conformational diversity. Science 299 1362 1367

36. JamesLCTawfikDS 2003 Conformational diversity and protein evolution--a 60-year-old hypothesis revisited. Trends Biochem Sci 28 361 368

37. ZimmermannJRomesbergFEBrooksCL3rdThorpeIF 2010 Molecular description of flexibility in an antibody combining site. J Phys Chem B 114 7359 7370

38. WedemayerGJPattenPAWangLHSchultzPGStevensRC 1997 Structural insights into the evolution of an antibody combining site. Science 276 1665 1669

39. LiYLipschultzCAMohanSSmith-GillSJ 2001 Mutations of an epitope hot-spot residue alter rate limiting steps of antigen-antibody protein-protein associations. Biochemistry 40 2011 2022

40. SinhaNMohanSLipschultzCASmith-GillSJ 2002 Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity. Biophys J 83 2946 2968

41. KourentziKSrinivasanMSmith-GillSJWillsonRC 2008 Conformational flexibility and kinetic complexity in antibody-antigen interactions. J Mol Recognit 21 114 121

42. PashovAMacLeodSSahaRPerryMVanCottTC 2005 Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12. Glycobiology 15 994 1001

43. PashovAGarimallaSMonzavi-KarbassiBKieber-EmmonsT 2009 Carbohydrate targets in HIV vaccine research: lessons from failures. Immunotherapy 1 777 794

44. PopeMGezelterSGalloNHoffmanLSteinmanRM 1995 Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J Exp Med 182 2045 2056